Search

everythinglearnresearchcommunity

for

Search:↓

Higher antigliadin antibody levels are linked to alopecia areata severity.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

Higher apelin-12 levels may indicate more severe acne.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Females are more affected by immune-related skin diseases, needing targeted health interventions.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

AI can predict hair loss patterns to improve care and treatment.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Tofacitinib may help treat severe hair loss, but more research is needed.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

New models predict male pattern baldness better than old ones but still need improvement.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Severe hair loss in women increases the risk of mental health issues, especially social anxiety.

People with alopecia areata often have lower vitamin D levels than healthy people.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

People with severe hair loss (Alopecia Areata) have different scalp bacteria than healthy people, which might help predict the condition's progress.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

STS01 1% effectively promotes hair regrowth with minimal side effects.